ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-04
DOI
10.1038/s41598-020-58864-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer
- (2019) Di Wu et al. Journal of Immunology Research
- ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
- (2019) Iris C. Salaroglio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemoresistance mechanisms of breast cancer and their countermeasures
- (2019) Xiwei Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity
- (2019) Norman Fultang et al. PLoS One
- A novel anti-triple negative breast cancer compound isolated from medicinal herb Myrothamnus flabellifolius
- (2018) Brar Jaspal et al. Journal of Medicinal Plants Research
- Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial
- (2017) Siker Kimbung et al. INTERNATIONAL JOURNAL OF CANCER
- Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis
- (2017) Claire Henry et al. Oncotarget
- Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype
- (2016) Kumiko Kida et al. BREAST CANCER RESEARCH AND TREATMENT
- Chromatin-Remodeling Complex SWI/SNF Controls Multidrug Resistance by Transcriptionally Regulating the Drug Efflux Pump ABCB1
- (2016) Ramin Dubey et al. CANCER RESEARCH
- Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells
- (2016) Eun-Hwa Jung et al. CELL BIOCHEMISTRY AND FUNCTION
- Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
- (2016) J Yu et al. LEUKEMIA
- Expression of ROR1 has prognostic significance in triple negative breast cancer
- (2016) Hui-Ping Chien et al. VIRCHOWS ARCHIV
- Fluorescence properties of several chemotherapy drugs: doxorubicin, paclitaxel and bleomycin
- (2016) Najme Sadat Hosseini Motlagh et al. Biomedical Optics Express
- RSK1 protects P-glycoprotein/ABCB1 against ubiquitin–proteasomal degradation by downregulating the ubiquitin-conjugating enzyme E2 R1
- (2016) Kazuhiro Katayama et al. Scientific Reports
- Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
- (2015) Aleix Prat et al. BMC Medicine
- Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
- (2015) Michael Y. Choi et al. Clinical Lymphoma Myeloma & Leukemia
- PI3K/Akt-mediated regulation of p53 in cancer
- (2014) Aswin G. Abraham et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The receptor tyrosine kinase ROR1 – An oncofetal antigen for targeted cancer therapy
- (2014) Mohammad Hojjat-Farsangi et al. SEMINARS IN CANCER BIOLOGY
- Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells
- (2013) H Sui et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine
- (2013) XIA XIE et al. ONCOLOGY REPORTS
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
- (2012) Suping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia
- (2012) Vincent T. Bicocca et al. CANCER CELL
- ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
- (2012) Suping Zhang et al. PLoS One
- Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer
- (2008) Edith A. Perez BREAST CANCER RESEARCH AND TREATMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now